Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Howard Liu, D.S.

Concepts (49)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Oropharyngeal Neoplasms320214631.180 Why?
Lymphatic Metastasis2202129750.850 Why?
Alphapapillomavirus220212270.810 Why?
Radiosurgery4202113500.760 Why?
Papillomavirus Infections3202115160.760 Why?
Mouth Neoplasms220226090.700 Why?
Papillomaviridae3202111440.600 Why?
Carcinoma, Hepatocellular3202120890.530 Why?
Liver Neoplasms3202141020.420 Why?
Lymph Nodes1202134330.360 Why?
Head and Neck Neoplasms4202227450.300 Why?
Carcinoma, Squamous Cell4202240380.270 Why?
Neck Dissection220202190.200 Why?
Australia1202113200.160 Why?
Retrospective Studies62021726080.120 Why?
Aged, 80 and over42022585280.110 Why?
Skin Neoplasms2202153350.100 Why?
Fluorodeoxyglucose F181201820280.090 Why?
Radiopharmaceuticals1201827600.080 Why?
Disease-Free Survival1201870560.080 Why?
Carcinoma, Renal Cell1202129680.080 Why?
Aged520221628620.070 Why?
Kidney Neoplasms1202140460.070 Why?
Young Adult32022562490.070 Why?
Radiotherapy, Adjuvant2202218410.060 Why?
Neoplasm Recurrence, Local2202189440.060 Why?
Middle Aged520222150540.060 Why?
Smoking1202189480.060 Why?
Sensitivity and Specificity12018149040.060 Why?
Adult420222124700.060 Why?
Melanoma1202152600.060 Why?
Radiotherapy Dosage2202029550.060 Why?
Humans1220227172800.060 Why?
Neoplasm Staging32021112000.050 Why?
Male620223513990.040 Why?
Lung Neoplasms12021126080.040 Why?
Female620223779340.040 Why?
Follow-Up Studies12018393020.040 Why?
Carboplatin120188070.030 Why?
Clinical Trials, Phase III as Topic120188180.030 Why?
Radiation Injuries1202012260.030 Why?
Postoperative Care1201815120.030 Why?
Combined Modality Therapy1202089250.020 Why?
Patient Selection1202043210.020 Why?
Prospective Studies22021512770.020 Why?
Survival Rate12018132620.010 Why?
Practice Guidelines as Topic1202074860.010 Why?
Randomized Controlled Trials as Topic1201895780.010 Why?
Treatment Outcome12021623440.010 Why?
Liu's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (49)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.